NEON logo

NeonMind Biosciences Inc. Stock Price

CNSX:NEON Community·CA$5.6k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

NEON Share Price Performance

CA$0
0.00 (0.00%)
CA$0
0.00 (0.00%)
Price CA$0

NEON Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Weak fundamentals or lack of information.

5 Risks
1 Reward

NeonMind Biosciences Inc. Key Details

CA$0

Revenue

CA$0

Cost of Revenue

CA$0

Gross Profit

CA$934.1k

Other Expenses

-CA$934.1k

Earnings

Last Reported Earnings
Feb 28, 2023
Next Reporting Earnings
n/a
-0.83
0%
0%
-78.6%
View Full Analysis

About NEON

Founded
2019
Employees
n/a
CEO
Robert Tessarolo
WebsiteView website
www.neonmindbiosciences.com

NeonMind Biosciences Inc. engages in the drug development of psychedelic compounds in Canada. It operates in two divisions, Pharmaceutical and Medical Services. The company’s lead product candidate is the NEO-001, a high-dose psilocybin for the treatment of obesity. It is also developing NEO-002, a low-dose psilocybin for the treatment of obesity. The company was formerly known as Flourish Mushroom Labs Inc. and changed its name to NeonMind Biosciences Inc. in April 2020. NeonMind Biosciences Inc. was incorporated in 2019 and is based in Oakville, Canada.

Recent NEON News & Updates

Recent updates

No updates

NeonMind Biosciences Inc. Competitors